In order to strenghten its leading position on preclinical expertise in the field of Dermatology, ETAP-Lab finalizes the development of a model of atopic dermatitis in BALB/c mice using the chemical agent DNCB. This model will shortly be added to ETAP-Lab’s catalog in order to test new active compounds against this pathology.
For more information please contact us.
